Bank Of America Corp Lipocine Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.3 - $0.58 $59 - $114	-198 Reduced 16.53%	1,000 $0
Q4 2022 Feb 10, 2023	BUY	$0.37 - $8.65 $73 - $1,712	198 Added 19.8%	1,198 $0
Q1 2022 May 16, 2022	SELL	$0.89 - $1.85 $148 - $308	-167 Reduced 14.31%	1,000 $1,000
Q4 2021 Feb 08, 2022	SELL	$0.99 - $1.2 $979 - $1,186	-989 Reduced 45.87%	1,167 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.08 - $1.49 $1,203 - $1,659	1,114 Added 106.91%	2,156 $2,000
Q2 2021 Sep 13, 2021	BUY	$1.17 - $1.59 $1,219 - $1,656	1,042 New	1,042 $1,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $433M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.